Amid an evolving landscape of anticancer agents, numerous approaches to elicit tumor-specific ... with antigen-positive tumors; the number of potential antigenic epitopes; and surface expression ...

Advancements in Antigen Selection for CRC CAR-T Cell Therapies Introducing specific targets for CAR-T cell therapy in CRC is essential ... 37 Natural killer group 2 member D ligands are stress-induced ...

For convenience, these antigens may be grouped into those cell surface antigens detected by transplantation ... provided inhibition of tumor cell growth. Similar results have been recorded recently ...

While cysteines are rare on the surface of general proteins, they can be artificially introduced ... This facilitates the presentation of cancer antigens to activate tumor antigen-specific immune ...

antigen expression in cancer stem cells; the frequency of patients with antigen-positive tumors; the number of potential antigenic epitopes; and surface expression of the antigen. From published ...

These updates will benefit about 66,000 people annually. The National Health Insurance Administration (NHIA) has added 30 ...

Prostate-Specific Membrane Antigen (PSMA) is a highly expressed and structurally unique target specific to prostate cancer (PCa). Diagnostic and therapeutic approaches in nuclear medicine, coupling ...

Mol Cancer Ther (2025) 24 (1): 93–104.

Chimeric antigen receptor-T (CAR-T) cell therapy ... potential of CAR-T cell therapy in CRC by analyzing clinical trials and highlighting prominent CRC-specific targets. We discuss the challenges such ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...